{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:00:58Z","timestamp":1780938058468,"version":"3.54.1"},"reference-count":78,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016619","name":"MyoKardia Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol Myers Squibb"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2675850","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:27:35Z","timestamp":1780936055000},"page":"1595-1616","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspective"],"prefix":"10.1080","volume":"29","author":[{"given":"Varun","family":"Ektare","sequence":"first","affiliation":[{"name":"OPEN Health Group","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0822-7261","authenticated-orcid":false,"given":"Claire","family":"Simons","sequence":"additional","affiliation":[{"name":"OPEN Health Group","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8075-8003","authenticated-orcid":false,"given":"Kasper","family":"Johannesen","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5681-8497","authenticated-orcid":false,"given":"Taryn","family":"Krause","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Uxbridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4014-2340","authenticated-orcid":false,"given":"Carla L.","family":"Zema","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6767-4614","authenticated-orcid":false,"given":"Leander R.","family":"Buisman","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Treur","sequence":"additional","affiliation":[{"name":"OPEN Health Group","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-9073","authenticated-orcid":false,"given":"Ana","family":"Moura","sequence":"additional","affiliation":[{"name":"OPEN Health Group","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikanta","family":"Dasari","sequence":"additional","affiliation":[{"name":"OPEN Health Group","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Verkaik","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6498-2950","authenticated-orcid":false,"given":"Gijs","family":"van de Wetering","sequence":"additional","affiliation":[{"name":"OPEN Health Group","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6400-2879","authenticated-orcid":false,"given":"Linde","family":"Pronk","sequence":"additional","affiliation":[{"name":"OPEN Health Group","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Pompen","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Contente","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Uxbridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5457-3010","authenticated-orcid":false,"given":"Christian","family":"Knackstedt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands and Member of the European Reference network for rare, low prevalence and complex diseases of the heart-ERN GUARD \u2013Heart"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-0280","authenticated-orcid":false,"given":"Michael","family":"Hurst","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Uxbridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.644682"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.02.014"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24207"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31792-X"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(21)01891-X"},{"issue":"1","key":"e_1_3_6_8_1","first-page":"164","article-title":"Mavacamten treatment for symptomatic obstructive hypertrophic cardiomyopathy: interim results from the MAVA-LTE study, EXPLORER-LTE cohort","volume":"12","author":"Rader F","year":"2024","unstructured":"Rader F, Or\u0119ziak A, Choudhury L, et al. Mavacamten treatment for symptomatic obstructive hypertrophic cardiomyopathy: interim results from the MAVA-LTE study, EXPLORER-LTE cohort. JACC Heart Fail. 2024;12(1):164\u2013177.","journal-title":"JACC Heart Fail"},{"key":"e_1_3_6_9_1","unstructured":"European Medicines Agency. Camzyos: EPAR - Product information. 2023. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/camzyos-epar-product-information_en.pdf"},{"key":"e_1_3_6_10_1","unstructured":"CADTH. CADTH Reimbursement Recommendation mavacamten (Camzyos). 2023. https:\/\/www.cda-amc.ca\/sites\/default\/files\/DRR\/2023\/SR0755%20Camzyos%20-%20Draft%20CADTH%20Recommendation%20March%2013%2C%202023%20-%20For%20posting.pdf"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-025-01808-0"},{"key":"e_1_3_6_12_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Opinion on Drugs: CAMZYOS (mavacamten) - Obstructive hypertrophic cardiomyopathy. 2023. https:\/\/www.has-sante.fr\/jcms\/p_3470375\/en\/camzyos-mavacamten-obstructive-hypertrophic-cardiomyopathy"},{"key":"e_1_3_6_13_1","unstructured":"Staatscourant van het Koninkrijk der Nederlanden. Regeling van de Minister voor Medische Zorg van 21 mei 2024 kenmerk 3835363-1064905-GMT houdende GVS regeling juni. 2024. https:\/\/zoek.officielebekendmakingen.nl\/stcrt-2024-17229.html."},{"key":"e_1_3_6_14_1","unstructured":"The National Institute for Health and Care Excellence (NICE). TA913: mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy. 2023. https:\/\/www.nice.org.uk\/guidance\/ta913."},{"key":"e_1_3_6_15_1","unstructured":"Zorginstituut Nederland. GVS-advies mavacamten (Camzyos\u00ae) voor de behandeling van een bepaalde hartspierziekte. 2024. https:\/\/www.zorginstituutnederland.nl\/publicaties\/adviezen\/2024\/05\/01\/gvs-advies-mavacamten-camzyos-bij-hocm"},{"key":"e_1_3_6_16_1","unstructured":"Zorginstituut Nederland. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg (versie 2016). 2016. https:\/\/www.zorginstituutnederland.nl\/publicaties\/publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199813040-00003"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.5603\/KP.2014.0212"},{"key":"e_1_3_6_19_1","unstructured":"Nederlandse Vereniging voor Cardiologie. Richtlijnen. 2026. https:\/\/www.nvvc.nl\/commissies\/thema-kwaliteit\/default.aspx"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae579"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.01.023"},{"issue":"5","key":"e_1_3_6_22_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchf.2017.09.011","article-title":"Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy","volume":"6","author":"Maron BJ","year":"2018","unstructured":"Maron BJ, Rowin EJ, Udelson JE, et al. Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy. JACC Heart Fail. 2018;6(5):353\u2013363.","journal-title":"JACC Heart Fail"},{"key":"e_1_3_6_23_1","unstructured":"Puscas T Reant P Donal E et al. Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: real-life data from the French REMY register. ESS-HF; 2023."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080142"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivs352"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2023.06.001"},{"key":"e_1_3_6_27_1","volume-title":"An economic systematic literature review for hypertrophic obstructive cardiomyopathy","author":"Krause T","year":"2024","unstructured":"Krause T, Slater D, Boulton E, et al. An economic systematic literature review for hypertrophic obstructive cardiomyopathy. Atlanta, GA: ISPOR; 2024."},{"key":"e_1_3_6_28_1","unstructured":"Centraal Bureau voor de Statistiek (CBS). Prognose periode-levensverwachting; geslacht en leeftijd 2020-2070. 2021. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/84883NED\/table?ts=1616485891825."},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2022.100244"},{"key":"e_1_3_6_30_1","volume-title":"Prognostic factors and surrogate endpoints in obstructive hypertrophic cardiomyopathy: a systematic literature review","author":"Krause T","year":"2023","unstructured":"Krause T, Fleming A, Hurst M, et al. Prognostic factors and surrogate endpoints in obstructive hypertrophic cardiomyopathy: a systematic literature review. Copenhagen, Denmark: ISPOR EU; 2023."},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.4534"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2277076"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2022.03.101"},{"key":"e_1_3_6_34_1","unstructured":"Bristol Myers Squibb. SHaRe registry analysis: mortality by NYHA Data on file; 2021."},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103062"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.01.003"},{"key":"e_1_3_6_37_1","unstructured":"G-standaard. Z-index September; 2023."},{"key":"e_1_3_6_38_1","unstructured":"Centraal Bureau voor de Statistiek. Statline - Consumtentprijzen; prijsindex. Gezondheid. 2022. https:\/\/opendata.cbs.nl\/#\/CBS\/nl\/dataset\/83131NED\/table"},{"key":"e_1_3_6_39_1","unstructured":"Centraal Bureau voor Statistiek. Statline. Consumtentprijzen; prijsindex. Alle bestedingen. 2022. https:\/\/opendata.cbs.nl\/#\/CBS\/nl\/dataset\/83131NED\/table."},{"key":"e_1_3_6_40_1","unstructured":"Nederlandse Zorgautoriteit. Opendisdata: open data van de Nederlandse Zorgautoriteit. 2022. https:\/\/www.opendisdata.nl\/."},{"key":"e_1_3_6_41_1","unstructured":"Hakkaart-van Roijen L Van der Linden N Bouwmans C et al. Kostenhandleiding: methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. 2016. https:\/\/www.zorginstituutnederland.nl\/over-ons\/publicaties\/publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg."},{"key":"e_1_3_6_42_1","unstructured":"Centraal Bureau voor Statistiek (CBS). Statline - Vacatures SBI 2008; naar economische acitiveit en bedrijfsgrootte. 2022. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/80472ned\/table?ts=1573031847873"},{"key":"e_1_3_6_43_1","unstructured":"Centraal Bureau voor Statistiek (CBS). StatLine. 2022. Arbeidsdeelname https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/82309NED\/table?fromstatweb."},{"key":"e_1_3_6_44_1","unstructured":"Rijksoverheid. AOW-leeftijd stijgt minder snel; 2022."},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.10.015"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.07.004"},{"key":"e_1_3_6_47_1","unstructured":"Mastenbroek CG Van der Meer FM Zwaap J et al. Pakketbeheer in de praktijk 2006 College voor zorgverzekeringen Zorginstituut Nederland; 2006."},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00810-8"},{"key":"e_1_3_6_49_1","unstructured":"Zwaap J Knies S van der Meijden C et al. Kosteneffectiviteit in de praktijk minister van Volksgezondheid Welzijn en Sport; 2015."},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1636732"},{"key":"e_1_3_6_51_1","unstructured":"Bristol Myers Squibb (BMS). Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025. 2025. https:\/\/news.bms.com\/news\/corporate-financial\/2025\/Bristol-Myers-Squibb-Presents-Real-World-Outcomes-of-Camzyos-mavacamten-Across-Four-Continents-at-the-European-Society-of-Cardiology-ESC-Congress-2025\/default.aspx"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.048"},{"key":"e_1_3_6_53_1","unstructured":"The National Institute for Health and Care Excellence (NICE). Health Technology Appraisal scope: mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID3928]. 2022."},{"key":"e_1_3_6_54_1","unstructured":"Pharmaceutical Benefits Advisory Committee. Pharmaceutical Benefits Advisory Committee (PBAC) Meeting Outcomes: november 2023 PBAC Meeting. 2023. Available from: https:\/\/www.pbs.gov.au\/industry\/listing\/elements\/pbac-meetings\/pbac-outcomes\/2023-11\/pbac-web-outcomes-11-2023-v2.pdf."},{"key":"e_1_3_6_55_1","unstructured":"European Medicines Agency. CAMZYOS - Summary of Opinion. 2023. https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-camzyos_en.pdf"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.2038"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.069378"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.33963\/KP.a2021.0112"},{"key":"e_1_3_6_59_1","doi-asserted-by":"crossref","unstructured":"Fifer S Pendleton A Godsell J et al. The experiences values and goals of patients in Australia living with obstructive hypertrophic cardiomyopathy: in\u2011depth patient interviews. 73rd Annual Scientific Session & Expo of the American College of Cardiology; Atlanta GA. 2024.","DOI":"10.1016\/S0735-1097(24)02434-3"},{"key":"e_1_3_6_60_1","unstructured":"Zorginstituut Nederland. Farmaco-Economisch rapport voor sacubitril\/valsartan (Entresto\u00ae) bij de behandeling van symptomatisch chronisch hartfalen. 2016. https:\/\/www.zorginstituutnederland.nl\/publicaties\/rapport\/2016\/04\/05\/sacubitril-valsartan-entresto-bij-symptomatisch-chronisch-hartfalen-met-verminderde-ejectiefractie"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00700.x"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1038"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01600-5"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.027"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.0252"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2023.04.028"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028693"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.1853"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.01.034"},{"issue":"2","key":"e_1_3_6_70_1","first-page":"86","article-title":"Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy","volume":"4","author":"Mutlak D","year":"2002","unstructured":"Mutlak D, Gruberg L, Reisner S, et al. Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy. Isr Med Assoc J. 2002;4(2):86\u201390.","journal-title":"Isr Med Assoc J"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.7775\/rac.v83.i3.5919"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2018.12.007"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2023.01.013"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2017.08.063"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005604"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.07.022"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2022.05.062"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.07.075"},{"key":"e_1_3_6_79_1","volume-title":"Economic burden of obstructive hypertrophic cardiomyopathy in France","author":"Charron P","year":"2023","unstructured":"Charron P, Zema C, Cott\u00e9 F-E, et al. Economic burden of obstructive hypertrophic cardiomyopathy in France. Copenhagen, Denmark: ISPOR Europe; 2023."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2675850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:27:59Z","timestamp":1780936079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2675850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2675850"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2675850","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}